Definitions
Epithelial cells line the surface of the intestine, lung, kidney, and liver and form regulated boundaries between compartments within an organism. By forming a barrier between disparate environments, epithelial cells play a number of important roles in regulating host physiology. They prevent dissipation of concentration gradients between the compartments they separate. They also keep endogenous bacteria, microbial products, and bioactive substances from escaping their internal environment in the gut lumen and lung by acting as a fence preventing translocation of these products into the systemic circulation or lymph. Epithelial cells also have a crucial role in microbial surveillance, communicating with immune cells through cytokines and chemokines. Finally, gut epithelial cells regulate the absorption and secretion of fluids, electrolytes, and nutrients.
With the exception of increased apoptosis in the gut, histologic analysis of the epithelium is unremarkable in either human autopsy studies of critical illness (1) or murine models of sepsis (2) . Nonetheless, multiple studies suggest that epithelial dysfunction plays a crucial role in the pathogenesis of organ failure (3). This review will focus on how critical illness worsens epithelial barrier function through alterations in the structure and function of tight junctions and how changes in epithelial apoptosis may contribute to organ dysfunction.
Epithelial Barrier Dysfunction in Critical Illness
The area of cell-cell contact in the epithelium is the intercellular junctional complex ( Fig. 1) (4) . The most apical portion of this complex is the tight junction (TJ), which separates the apical and basal components of the epithelia, maintaining cell polarity. The TJ acts as a semipermeable membrane, limiting paracellular transport of solutes and ions between compartments. The adherens junction and desmosome are more basal than the TJ and increase the mechanical strength of the junctional complex.
Incubating cultured epithelial monolayers with proinflammatory cytokines leads to increased permeability. Data from Fink et al. (3) show that nitric oxide (NO) plays an important role in altered barrier function. Compounds that increase NO production cause increased epithelial permeability in vitro (5) , whereas inhibiting inducible nitric oxide synthase (iNOS) partially prevents cytokineinduced increases in permeability (6) . Additional studies suggest that production of peroxynitrite (formed by a reaction between NO and superoxide) may be more important than NO per se in altering epithelial barrier function (3).
One mechanism through which NO affects permeability is by altering TJ structure and function. TJs are made of at least four integral membrane proteins (including occludin and claudins) (4). These are linked to a series of peripheral membrane proteins (including ZO-1, ZO-2, and ZO-3) that anchor the integral membrane proteins to the cytoplasm and cytoskeleton as well as recruit regulatory molecules to the TJ. Incubation of intestinal epithelial cells with a nitric oxide donor causes decreased expression of ZO-1, ZO-3, and occludin and increased expression of claudin-1 (7) . It also leads to incorrect subcellular localization of ZO-1, occludin, and claudin-1. Of note, cytokine-induced changes in the levels and localization of TJ proteins are reversed by coincubation with a NO scav-enger. One way NO might alter the structure or function of TJ functions is via modulation of the membrane pump Na ϩ K ϩ adenosine triphosphatase (AT-Pase), since incubating intestinal epithelial cells in vitro with NO decreases both the expression of and activity of Na ϩ K ϩ ATPase (8) . Based on these findings, Fink et al. (3) proposed the following paradigm for how systemic inflammation leads to epithelial dysfunction: proinflammatory cytokines 3 iNOS induction 3 production of NO 3 inhibition of Na ϩ K ϩ ATPase 3 altered expression and/or subcellular localization of TJ proteins 3 increase in permeability (3).
Similar findings linking NO, TJs, and epithelial dysfunction have also been demonstrated in vivo. Sublethal endotoxin injection causes impaired intestinal, pulmonary, and hepatic barrier function in mice (9 -11) . This is associated with derangements in both TJ protein levels and subcellular localization, which can be blocked pharmacologically by giving a compound that blocks iNOS. Similarly, iNOS Ϫ/Ϫ mice do not develop additional abnormalities in TJ protein levels and localization following lipopolysaccharide injection.
Increased epithelial permeability can have a number of manifestations, depending on the tissue being examined. For instance, intestinal barrier failure may be associated with translocation of bacteria, microbial products, or bioactive substances from the gut lumen into the systemic circulation or lymph. There is little doubt that intestinal hyperpermeability occurs in critical illness, and this decrease in barrier function has been repeatedly shown to be associated with increased complications (12) . However, translocation of live bacteria and/or endotoxin is uncommon in critical illness (13) . This does not mean that increased gut permeability is unimportant. Delivery of bacterial toxins into the systemic circulation (14) may play an important role in the pathogenesis of sepsis. In addition, epithelial dysfunction may lead to an in-crease in gut-derived bioactive substances in mesenteric lymph, which have been shown to cause lung and endothelial injury in animals subjected to either trauma/hemorrhage or thermal injury (15) .
Functional abnormalities in lung epithelium may also lead to translocation, whereas abnormal pulmonary TJ formation can lead to alveolar flooding and pulmonary edema. It has also been proposed that renal epithelial dysfunction may cause back-leakage of tubular fluid, potentially contributing to acute renal failure (3) . Similarly, back-leakage of bile due to liver epithelial dysfunction may play a role in the pathogenesis of cholestatic jaundice (16) .
Epithelial Cell Death in Critical Illness
A different way critical illness can affect epithelial function is by alterations in cell death and/or cell production. Gut epithelial apoptosis is up-regulated in sepsis both in human autopsy studies of septic patients and in animal models of critical illness (Fig. 2) (1, 2) . Studies from our laboratory suggest that elevated intestinal cell death is detrimental to survival in critical illness. Intestinal overexpression of the antiapoptotic protein Bcl-2 in transgenic mice prevents sepsis-induced gut epithelial apoptosis in cecal ligation and puncture (17) or Pseudomonas aeruginosa pneumonia (18) , and this decrease in cell death is associated with a marked decrease in mortality rate. Although the mechanism through which gut overexpression of Bcl-2 improves survival in septic animals remains unclear, neither bacterial translocation nor systemic cytokine levels are affected by prevention of intestinal apoptosis. Strengthening the argument that intestinal cell death is important in critical illness is the observation that a mechanistically dis- tinct method of decreasing gut epithelial apoptosis is also associated with improved survival in noninfectious inflammation. Transgenic mice that have a mutation that interferes with the caspase cleavage site of retinoblastoma protein have preferentially decreased gut epithelial (but not lymphocyte) apoptosis while simultaneously having improved survival following endotoxemia (19) . The pathways through which critical illness induces gut epithelial apoptosis remain to be fully determined, although burninduced intestinal cell death can be abrogated by giving anti-tumor necrosis factor-␣ antibody immediately after thermal injury (20) . Of note, although sepsis increases intestinal cell death, it simultaneously decreases gut epithelial proliferation, and decreases in cellular production can be partially reversed by preventing cell death (21) .
Although human autopsy studies and murine studies of septic animals do not show widespread epithelial apoptosis, the lung epithelium is susceptible to programmed cell death in critical illness. Soluble Fas ligand is present in higher concentrations in BAL fluid at the onset of ARDS in patients who will ultimately die of this disease (22) . Importantly, BAL fluid from patients with ARDS causes Fasdependent apoptosis in cultured distal lung epithelial cells, whereas BAL fluid from patients without ARDS does not cause lung cell death. Type I pneumocytes in patients express both Fas and Fas ligand, and it has been hypothesized that these cells have increased susceptibility to apoptosis in acute lung injury or acute respiratory distress syndrome, although definitive proof to support this is lacking. Pneumonia with either Gram-positive or Gram-negative organisms has also been shown to cause lung epithelial apoptosis in animal studies. Scattered reports also show increased liver or kidney apoptosis in specific disease states (following Listeria monocytogenes infection or endotoxemia, respectively), but cell death in these organs is unlikely to play a major role in human sepsis.
Since alterations in the epithelium can lead to severe abnormalities in nearly every organ system, epithelial cell dysfunction has been postulated to be a unifying theme in the pathogenesis of critical illness (3) . Although no targeted therapy aimed at TJs or epithelial apoptosis is currently used in clinical practice, further research to understand mechanisms underlying epithelial dysfunction may ultimately translate into the development of novel therapeutics aimed at restoring epithelial integrity in the critically ill.
